Effects of High Fruit, Vegetable, and Dairy Intake on Plasma Lipids and Blood Pressure in Healthy Individuals

March 25, 2015 updated by: UCSF Benioff Children's Hospital Oakland

Effects of a Modified Lower Carbohydrate, Higher Fat DASH Diet Plan on Plasma Lipids, Lipoprotein Particle Size, and Blood Pressure in Healthy Adults

The Dietary Approaches to Stop Hypertension (DASH) trial has been shown to reduce blood pressure and plasma total and LDL-cholesterol (C) compared to a Western diet, but shows no benefit on other blood lipid variables associated with cardiovascular disease (CVD) risk, namely HDL-cholesterol and triglycerides. The overall objective of this study is to determine whether modification of the DASH diet by substituting carbohydrate with fat will result in improvements in multiple biomarkers of CVD risk. Specifically, the investigators will test the hypotheses that modification of the DASH diet by reducing carbohydrate, primarily in the form of simple sugars and glycemic starches, and allowing for a more liberal intake of total and saturated fat, primarily from dairy foods, will: (1) improve lipoprotein markers of CVD risk (reduced total/HDL-C ratio, apolipoprotein B, small LDL particles, and increased HDL-C, apoAI, and large HDL particles); and (2) result in comparable reductions of systolic and diastolic blood pressure to those achieved with the standard DASH diet. The investigators will also assess the effects of the modified DASH diet on markers of insulin resistance and inflammation. Our main hypotheses will be tested by a controlled dietary intervention conducted in 40 healthy men and women who will be randomly allocated to consume, for 3 weeks each, a control Western diet, a standard DASH diet, and a modified low-carbohydrate DASH diet, separated by 2-week washout periods.

Study Overview

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Berkeley, California, United States, 94705
        • Cholesterol Research Center, Children's Hospital Oakland Research Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

22 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 22 years and older
  • Average systolic blood pressure <160 mm Hg and diastolic blood pressure 80 - 95 mm Hg measured on 2 separate days
  • Non-smoking
  • Agrees to abstain from alcohol and dietary supplements during the study
  • Willing to consume all study foods as instructed

Exclusion Criteria:

  • History of coronary heart disease, cerebrovascular disease, peripheral vascular disease, bleeding disorder, liver or renal disease, diabetes, lung disease, HIV, or cancer (other than skin cancer) in the last 5 years.
  • Taking hormones or drugs known to affect lipid metabolism or blood pressure.
  • Body Mass Index (BMI) > 35
  • Total- and LDL-cholesterol > 95th percentile for sex and age.
  • Fasting triglycerides > 500 mg/dl.
  • Fasting blood sugar (FBS) > 126 mg/dl.
  • Abnormal thyroid stimulating hormone
  • Not weight stable
  • Pregnant or breast-feeding

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Dietary Intervention: Control Diet
3 weeks of a typical Western diet pattern. 48% carbohydrate, 15% protein, 37% fat.
3 weeks of a diet based on the Dietary Approaches to Stop Hypertension (DASH) diet plan. 57% carbohydrate, 18% protein, 25% fat.
3 weeks of a reduced carbohydrate, higher fat modification of the DASH diet plan. 42% carbohydrate, 18% protein, 40% fat.
Experimental: Dietary Intervention: DASH-based diet
3 weeks of a typical Western diet pattern. 48% carbohydrate, 15% protein, 37% fat.
3 weeks of a diet based on the Dietary Approaches to Stop Hypertension (DASH) diet plan. 57% carbohydrate, 18% protein, 25% fat.
3 weeks of a reduced carbohydrate, higher fat modification of the DASH diet plan. 42% carbohydrate, 18% protein, 40% fat.
Experimental: Dietary Intervention: Modified DASH diet
3 weeks of a typical Western diet pattern. 48% carbohydrate, 15% protein, 37% fat.
3 weeks of a diet based on the Dietary Approaches to Stop Hypertension (DASH) diet plan. 57% carbohydrate, 18% protein, 25% fat.
3 weeks of a reduced carbohydrate, higher fat modification of the DASH diet plan. 42% carbohydrate, 18% protein, 40% fat.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Total:HDL-cholesterol ratio
Time Frame: 4 weeks
4 weeks
HDL-cholesterol
Time Frame: 4 weeks
4 weeks
Apolipoprotein B
Time Frame: 4 weeks
4 weeks
Apolipoprotein AI
Time Frame: 4 weeks
4 weeks
Small LDL particles
Time Frame: 4 weeks
4 weeks
Large HDL particles
Time Frame: 4 weeks
4 weeks
Total:HDL-cholesterol ratio
Time Frame: 9 weeks
9 weeks
Total:HDL-cholesterol ratio
Time Frame: 14 weeks
14 weeks
HDL-cholesterol
Time Frame: 9 weeks
9 weeks
HDL-cholesterol
Time Frame: 14 weeks
14 weeks
Apolipoprotein B
Time Frame: 9 weeks
9 weeks
Apolipoprotein B
Time Frame: 14 weeks
14 weeks
Apolipoprotein AI
Time Frame: 9 weeks
9 weeks
Apolipoprotein AI
Time Frame: 14 weeks
14 weeks
Small LDL particles
Time Frame: 9 weeks
9 weeks
Small LDL particles
Time Frame: 14 weeks
14 weeks
Large HDL particles
Time Frame: 9 weeks
9 weeks
Large HDL particles
Time Frame: 14 weeks
14 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Blood Pressure
Time Frame: End of each experimental diet (4 wks, 9 wks, and 14 wks)
End of each experimental diet (4 wks, 9 wks, and 14 wks)
Triglycerides
Time Frame: End of each experimental diet (4 wks, 9 wks, and 14 wks)
End of each experimental diet (4 wks, 9 wks, and 14 wks)
Total Cholesterol
Time Frame: End of each experimental diet (4 wks, 9 wks, and 14 wks)
End of each experimental diet (4 wks, 9 wks, and 14 wks)
LDL-Cholesterol
Time Frame: End of each experimental diet (4 wks, 9 wks, and 14 wks)
End of each experimental diet (4 wks, 9 wks, and 14 wks)
Lipoprotein Subclasses (HDL, LDL, IDL, VLDL)
Time Frame: End of each experimental diet (4 wks, 9 wks, and 14 wks)
End of each experimental diet (4 wks, 9 wks, and 14 wks)
HOMA-IR
Time Frame: End of each experimental diet (4 wks, 9 wks, and 14 wks)
End of each experimental diet (4 wks, 9 wks, and 14 wks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2011

Primary Completion (Actual)

December 1, 2013

Study Completion (Actual)

December 1, 2013

Study Registration Dates

First Submitted

July 22, 2011

First Submitted That Met QC Criteria

July 27, 2011

First Posted (Estimate)

July 28, 2011

Study Record Updates

Last Update Posted (Estimate)

March 26, 2015

Last Update Submitted That Met QC Criteria

March 25, 2015

Last Verified

March 1, 2015

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Disease

Clinical Trials on Dietary Intervention

3
Subscribe